CompaniesCardiovalve

Cardiovalve

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

4

As Collaborator

2

Total Enrollment

141

By Phase

NA: 6

By Status

RECRUITING: 3WITHDRAWN: 2TERMINATED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
NCT03958773
NCT03339115
NCT03714412
NCT05486832
NCT04100720
Hover over trial bars to see details

Recent Trials

NCT04100720Collaborator
Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation
NAWithdrawn
Started: Feb 29, 2024 · Completed: Dec 31, 2030
NCT05486832Lead Sponsor
Safety and Performance of the Cardiovalve TR Replacement System
NARecruiting
100 participants
Started: Dec 9, 2022 · Completed: Dec 15, 2026
NCT03714412Lead Sponsor
Feasibility Study of Patients With Severe MR Treated With the Cardiovalve TMVR System
NAWithdrawn
Started: Sep 30, 2019 · Completed: Dec 15, 2023
NCT03813524Collaborator
Cardiovalve Transfemoral Mitral Valve System
NATerminated
1 participants
Started: Mar 26, 2019 · Completed: Mar 31, 2020
NCT03339115Lead Sponsor
AHEAD: European Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System
NARecruiting
30 participants
Started: Apr 23, 2018 · Completed: Dec 31, 2029
View all 6 trials →
Related Companies
Venus Medtech
acquired